Know Cancer

or
forgot password

A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors


N/A
18 Years
60 Years
Open (Enrolling)
Female
Uterine Cancer, Cervix Uteri Nos, Gestational Trophoblastic Disease

Thank you

Trial Information

A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors


Inclusion Criteria:



- Pathology confirmed GTD by MSKCC

- Sufficient proficiency in the English language to respond to quality of life surveys

- Age ≥ 18 years

- Benign or malignant disease

- Treated with surgery and/or chemotherapy or observation

Exclusion Criteria:

- None

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

The primary outcomes include reproductive concerns (as measured by the Reproductive Concern Scale, RCS) and sexual functioning (as measured by the Female Sexual Function Index, FSFI).

Outcome Time Frame:

conclusion of the study

Safety Issue:

No

Principal Investigator

Elizabeth Jewell, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

08-040

NCT ID:

NCT00706875

Start Date:

June 2008

Completion Date:

June 2014

Related Keywords:

  • Uterine Cancer
  • CERVIX UTERI NOS
  • Gestational Trophoblastic Disease
  • GTD survivors
  • questionnaires
  • GTD
  • Uterine Neoplasms
  • Gestational Trophoblastic Neoplasms

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021